|Bid||0.5700 x 1000|
|Ask||0.5769 x 1000|
|Day's Range||0.5501 - 0.5769|
|52 Week Range||0.4200 - 1.7900|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Oct 27, 2022 - Oct 31, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for IGC
POTOMAC, Md., August 08, 2022--IGC announces its financial results for the three months ended June 30, 2022, which is the first quarter of the Company’s 2023 fiscal year.
POTOMAC, Md., June 23, 2022--IGC Reports Financial Results for Fiscal Year Ended March 31, 2022.
BETHESDA, Md., June 21, 2022--IGC is excited to announce that one of its subsidiaries reached an IP license agreement for a potential Alzheimer’s drug development candidate.